Global Disease-Modifying Antirheumatic Drug Sales Market Report 2023

Report ID: 855274 | Published Date: Jan 2025 | No. of Page: 130 | Base Year: 2024 | Rating: 4.6 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Disease-Modifying Antirheumatic Drug Market Overview
    1.1 Disease-Modifying Antirheumatic Drug Product Scope
    1.2 Disease-Modifying Antirheumatic Drug Segment by Type
        1.2.1 Global Disease-Modifying Antirheumatic Drug Sales by Type (2016 & 2021 & 2027)
        1.2.2 Non-Steroidal Anti-Inflammatory Drugs
        1.2.3 Steroidal Anti-Inflammatory Drugs
        1.2.4 Slow Acting Drug
        1.2.5 Immunological Preparation
    1.3 Disease-Modifying Antirheumatic Drug Segment by Application
        1.3.1 Global Disease-Modifying Antirheumatic Drug Sales Comparison by Application (2016 & 2021 & 2027)
        1.3.2 Pharmaceutical Industry
        1.3.3 Hospital and Clinic
        1.3.4 Other
    1.4 Disease-Modifying Antirheumatic Drug Market Estimates and Forecasts (2016-2027)
        1.4.1 Global Disease-Modifying Antirheumatic Drug Market Size in Value Growth Rate (2016-2027)
        1.4.2 Global Disease-Modifying Antirheumatic Drug Market Size in Volume Growth Rate (2016-2027)
        1.4.3 Global Disease-Modifying Antirheumatic Drug Price Trends (2016-2027)

2 Disease-Modifying Antirheumatic Drug Estimates and Forecasts by Region
    2.1 Global Disease-Modifying Antirheumatic Drug Market Size by Region: 2016 VS 2021 VS 2027
    2.2 Global Disease-Modifying Antirheumatic Drug Retrospective Market Scenario by Region (2016-2021)
        2.2.1 Global Disease-Modifying Antirheumatic Drug Sales Market Share by Region (2016-2021)
        2.2.2 Global Disease-Modifying Antirheumatic Drug Revenue Market Share by Region (2016-2021)
    2.3 Global Disease-Modifying Antirheumatic Drug Market Estimates and Forecasts by Region (2022-2027)
        2.3.1 Global Disease-Modifying Antirheumatic Drug Sales Estimates and Forecasts by Region (2022-2027)
        2.3.2 Global Disease-Modifying Antirheumatic Drug Revenue Forecast by Region (2022-2027)
    2.4 Geographic Market Analysis: Market Facts & Figures
        2.4.1 North America Disease-Modifying Antirheumatic Drug Estimates and Projections (2016-2027)
        2.4.2 Europe Disease-Modifying Antirheumatic Drug Estimates and Projections (2016-2027)
        2.4.3 China Disease-Modifying Antirheumatic Drug Estimates and Projections (2016-2027)
        2.4.4 Japan Disease-Modifying Antirheumatic Drug Estimates and Projections (2016-2027)
        2.4.5 Southeast Asia Disease-Modifying Antirheumatic Drug Estimates and Projections (2016-2027)
        2.4.6 India Disease-Modifying Antirheumatic Drug Estimates and Projections (2016-2027)
3 Global Disease-Modifying Antirheumatic Drug Competition Landscape by Players
    3.1 Global Top Disease-Modifying Antirheumatic Drug Players by Sales (2016-2021)
    3.2 Global Top Disease-Modifying Antirheumatic Drug Players by Revenue (2016-2021)
    3.3 Global Disease-Modifying Antirheumatic Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Disease-Modifying Antirheumatic Drug as of 2020)
    3.4 Global Disease-Modifying Antirheumatic Drug Average Price by Company (2016-2021)
    3.5 Manufacturers Disease-Modifying Antirheumatic Drug Manufacturing Sites, Area Served, Product Type
    3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Disease-Modifying Antirheumatic Drug Market Size by Type
    4.1 Global Disease-Modifying Antirheumatic Drug Historic Market Review by Type (2016-2021)
        4.1.1 Global Disease-Modifying Antirheumatic Drug Sales Market Share by Type (2016-2021)
        4.1.2 Global Disease-Modifying Antirheumatic Drug Revenue Market Share by Type (2016-2021)
        4.1.3 Global Disease-Modifying Antirheumatic Drug Price by Type (2016-2021)
    4.2 Global Disease-Modifying Antirheumatic Drug Market Estimates and Forecasts by Type (2022-2027)
        4.2.1 Global Disease-Modifying Antirheumatic Drug Sales Forecast by Type (2022-2027)
        4.2.2 Global Disease-Modifying Antirheumatic Drug Revenue Forecast by Type (2022-2027)
        4.2.3 Global Disease-Modifying Antirheumatic Drug Price Forecast by Type (2022-2027)
5 Global Disease-Modifying Antirheumatic Drug Market Size by Application
    5.1 Global Disease-Modifying Antirheumatic Drug Historic Market Review by Application (2016-2021)
        5.1.1 Global Disease-Modifying Antirheumatic Drug Sales Market Share by Application (2016-2021)
        5.1.2 Global Disease-Modifying Antirheumatic Drug Revenue Market Share by Application (2016-2021)
        5.1.3 Global Disease-Modifying Antirheumatic Drug Price by Application (2016-2021)
    5.2 Global Disease-Modifying Antirheumatic Drug Market Estimates and Forecasts by Application (2022-2027)
        5.2.1 Global Disease-Modifying Antirheumatic Drug Sales Forecast by Application (2022-2027)
        5.2.2 Global Disease-Modifying Antirheumatic Drug Revenue Forecast by Application (2022-2027)
        5.2.3 Global Disease-Modifying Antirheumatic Drug Price Forecast by Application (2022-2027)

6 North America Disease-Modifying Antirheumatic Drug Market Facts & Figures
    6.1 North America Disease-Modifying Antirheumatic Drug Sales by Company
        6.1.1 North America Disease-Modifying Antirheumatic Drug Sales by Company (2016-2021)
        6.1.2 North America Disease-Modifying Antirheumatic Drug Revenue by Company (2016-2021)
    6.2 North America Disease-Modifying Antirheumatic Drug Sales Breakdown by Type
        6.2.1 North America Disease-Modifying Antirheumatic Drug Sales Breakdown by Type (2016-2021)
        6.2.2 North America Disease-Modifying Antirheumatic Drug Sales Breakdown by Type (2022-2027)
    6.3 North America Disease-Modifying Antirheumatic Drug Sales Breakdown by Application
        6.3.1 North America Disease-Modifying Antirheumatic Drug Sales Breakdown by Application (2016-2021)
        6.3.2 North America Disease-Modifying Antirheumatic Drug Sales Breakdown by Application (2022-2027)

7 Europe Disease-Modifying Antirheumatic Drug Market Facts & Figures
    7.1 Europe Disease-Modifying Antirheumatic Drug Sales by Company
        7.1.1 Europe Disease-Modifying Antirheumatic Drug Sales by Company (2016-2021)
        7.1.2 Europe Disease-Modifying Antirheumatic Drug Revenue by Company (2016-2021)
    7.2 Europe Disease-Modifying Antirheumatic Drug Sales Breakdown by Type
        7.2.1 Europe Disease-Modifying Antirheumatic Drug Sales Breakdown by Type (2016-2021)
        7.2.2 Europe Disease-Modifying Antirheumatic Drug Sales Breakdown by Type (2022-2027)
    7.3 Europe Disease-Modifying Antirheumatic Drug Sales Breakdown by Application
        7.3.1 Europe 130 Sales Breakdown by Application (2016-2021)
        7.3.2 Europe 130 Sales Breakdown by Application (2022-2027)

8 China Disease-Modifying Antirheumatic Drug Market Facts & Figures
    8.1 China Disease-Modifying Antirheumatic Drug Sales by Company
        8.1.1 China Disease-Modifying Antirheumatic Drug Sales by Company (2016-2021)
        8.1.2 China Disease-Modifying Antirheumatic Drug Revenue by Company (2016-2021)
    8.2 China Disease-Modifying Antirheumatic Drug Sales Breakdown by Type
        8.2.1 China Disease-Modifying Antirheumatic Drug Sales Breakdown by Type (2016-2021)
        8.2.2 China Disease-Modifying Antirheumatic Drug Sales Breakdown by Type (2022-2027)
    8.3 China Disease-Modifying Antirheumatic Drug Sales Breakdown by Application
        8.3.1 China 245 Sales Breakdown by Application (2016-2021)
        8.3.2 China 245 Sales Breakdown by Application (2022-2027)

9 Japan Disease-Modifying Antirheumatic Drug Market Facts & Figures
    9.1 Japan Disease-Modifying Antirheumatic Drug Sales by Company
        9.1.1 Japan Disease-Modifying Antirheumatic Drug Sales by Company (2016-2021)
        9.1.2 Japan Disease-Modifying Antirheumatic Drug Revenue by Company (2016-2021)
    9.2 Japan Disease-Modifying Antirheumatic Drug Sales Breakdown by Type
        9.2.1 Japan Disease-Modifying Antirheumatic Drug Sales Breakdown by Type (2016-2021)
        9.2.2 Japan Disease-Modifying Antirheumatic Drug Sales Breakdown by Type (2022-2027)
    9.3 Japan Disease-Modifying Antirheumatic Drug Sales Breakdown by Application
        9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
        9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Disease-Modifying Antirheumatic Drug Market Facts & Figures
    10.1 Southeast Asia Disease-Modifying Antirheumatic Drug Sales by Company
        10.1.1 Southeast Asia Disease-Modifying Antirheumatic Drug Sales by Company (2016-2021)
        10.1.2 Southeast Asia Disease-Modifying Antirheumatic Drug Revenue by Company (2016-2021)
    10.2 Southeast Asia Disease-Modifying Antirheumatic Drug Sales Breakdown by Type
        10.2.1 Southeast Asia Disease-Modifying Antirheumatic Drug Sales Breakdown by Type (2016-2021)
        10.2.2 Southeast Asia Disease-Modifying Antirheumatic Drug Sales Breakdown by Type (2022-2027)
    10.3 Southeast Asia Disease-Modifying Antirheumatic Drug Sales Breakdown by Application
        10.3.1 Southeast Asia MT Sales Breakdown by Application (2016-2021)
        10.3.2 Southeast Asia MT Sales Breakdown by Application (2022-2027)

11 India Disease-Modifying Antirheumatic Drug Market Facts & Figures
    11.1 India Disease-Modifying Antirheumatic Drug Sales by Company
        11.1.1 India Disease-Modifying Antirheumatic Drug Sales by Company (2016-2021)
        11.1.2 India Disease-Modifying Antirheumatic Drug Revenue by Company (2016-2021)
    11.2 India Disease-Modifying Antirheumatic Drug Sales Breakdown by Type
        11.2.1 India Disease-Modifying Antirheumatic Drug Sales Breakdown by Type (2016-2021)
        11.2.2 India Disease-Modifying Antirheumatic Drug Sales Breakdown by Type (2022-2027)
    11.3 India Disease-Modifying Antirheumatic Drug Sales Breakdown by Application
        11.3.1 India Disease-Modifying Antirheumatic Drug Sales Breakdown by Application (2016-2021)
        11.3.2 India Disease-Modifying Antirheumatic Drug Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Disease-Modifying Antirheumatic Drug Business
    12.1 AbbVie
        12.1.1 AbbVie Corporation Information
        12.1.2 AbbVie Business Overview
        12.1.3 AbbVie Disease-Modifying Antirheumatic Drug Sales, Revenue and Gross Margin (2016-2021)
        12.1.4 AbbVie Disease-Modifying Antirheumatic Drug Products Offered
        12.1.5 AbbVie Recent Development
    12.2 Amgen
        12.2.1 Amgen Corporation Information
        12.2.2 Amgen Business Overview
        12.2.3 Amgen Disease-Modifying Antirheumatic Drug Sales, Revenue and Gross Margin (2016-2021)
        12.2.4 Amgen Disease-Modifying Antirheumatic Drug Products Offered
        12.2.5 Amgen Recent Development
    12.3 Pfizer
        12.3.1 Pfizer Corporation Information
        12.3.2 Pfizer Business Overview
        12.3.3 Pfizer Disease-Modifying Antirheumatic Drug Sales, Revenue and Gross Margin (2016-2021)
        12.3.4 Pfizer Disease-Modifying Antirheumatic Drug Products Offered
        12.3.5 Pfizer Recent Development
    12.4 Roche Holding AG
        12.4.1 Roche Holding AG Corporation Information
        12.4.2 Roche Holding AG Business Overview
        12.4.3 Roche Holding AG Disease-Modifying Antirheumatic Drug Sales, Revenue and Gross Margin (2016-2021)
        12.4.4 Roche Holding AG Disease-Modifying Antirheumatic Drug Products Offered
        12.4.5 Roche Holding AG Recent Development
    12.5 Novartis International AG
        12.5.1 Novartis International AG Corporation Information
        12.5.2 Novartis International AG Business Overview
        12.5.3 Novartis International AG Disease-Modifying Antirheumatic Drug Sales, Revenue and Gross Margin (2016-2021)
        12.5.4 Novartis International AG Disease-Modifying Antirheumatic Drug Products Offered
        12.5.5 Novartis International AG Recent Development
    12.6 Johnson & Johnson
        12.6.1 Johnson & Johnson Corporation Information
        12.6.2 Johnson & Johnson Business Overview
        12.6.3 Johnson & Johnson Disease-Modifying Antirheumatic Drug Sales, Revenue and Gross Margin (2016-2021)
        12.6.4 Johnson & Johnson Disease-Modifying Antirheumatic Drug Products Offered
        12.6.5 Johnson & Johnson Recent Development
    12.7 Bristol-Myers Squibb
        12.7.1 Bristol-Myers Squibb Corporation Information
        12.7.2 Bristol-Myers Squibb Business Overview
        12.7.3 Bristol-Myers Squibb Disease-Modifying Antirheumatic Drug Sales, Revenue and Gross Margin (2016-2021)
        12.7.4 Bristol-Myers Squibb Disease-Modifying Antirheumatic Drug Products Offered
        12.7.5 Bristol-Myers Squibb Recent Development
    12.8 Merck
        12.8.1 Merck Corporation Information
        12.8.2 Merck Business Overview
        12.8.3 Merck Disease-Modifying Antirheumatic Drug Sales, Revenue and Gross Margin (2016-2021)
        12.8.4 Merck Disease-Modifying Antirheumatic Drug Products Offered
        12.8.5 Merck Recent Development
    12.9 UCB S.A.
        12.9.1 UCB S.A. Corporation Information
        12.9.2 UCB S.A. Business Overview
        12.9.3 UCB S.A. Disease-Modifying Antirheumatic Drug Sales, Revenue and Gross Margin (2016-2021)
        12.9.4 UCB S.A. Disease-Modifying Antirheumatic Drug Products Offered
        12.9.5 UCB S.A. Recent Development
    12.10 Eli Lilly and Company
        12.10.1 Eli Lilly and Company Corporation Information
        12.10.2 Eli Lilly and Company Business Overview
        12.10.3 Eli Lilly and Company Disease-Modifying Antirheumatic Drug Sales, Revenue and Gross Margin (2016-2021)
        12.10.4 Eli Lilly and Company Disease-Modifying Antirheumatic Drug Products Offered
        12.10.5 Eli Lilly and Company Recent Development

13 Disease-Modifying Antirheumatic Drug Manufacturing Cost Analysis
    13.1 Disease-Modifying Antirheumatic Drug Key Raw Materials Analysis
        13.1.1 Key Raw Materials
        13.1.2 Key Raw Materials Price Trend
        13.1.3 Key Suppliers of Raw Materials
    13.2 Proportion of Manufacturing Cost Structure
    13.3 Manufacturing Process Analysis of Disease-Modifying Antirheumatic Drug
    13.4 Disease-Modifying Antirheumatic Drug Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
    14.1 Marketing Channel
    14.2 Disease-Modifying Antirheumatic Drug Distributors List
    14.3 Disease-Modifying Antirheumatic Drug Customers

15 Market Dynamics
    15.1 Disease-Modifying Antirheumatic Drug Market Trends
    15.2 Disease-Modifying Antirheumatic Drug Drivers
    15.3 Disease-Modifying Antirheumatic Drug Market Challenges
    15.4 Disease-Modifying Antirheumatic Drug Market Restraints

16 Research Findings and Conclusion

17 Appendix
    17.1 Research Methodology
        17.1.1 Methodology/Research Approach
        17.1.2 Data Source
    17.2 Author List
    17.3 Disclaimer
List of Tables
    Table 1. Global Disease-Modifying Antirheumatic Drug Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
    Table 2. Global Disease-Modifying Antirheumatic Drug Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
    Table 3. Global Disease-Modifying Antirheumatic Drug Market Size (US$ Million) by Region: 2016 VS 2021 &2027
    Table 4. Global Disease-Modifying Antirheumatic Drug Sales (MT) by Region (2016-2021)
    Table 5. Global Disease-Modifying Antirheumatic Drug Sales Market Share by Region (2016-2021)
    Table 6. Global Disease-Modifying Antirheumatic Drug Revenue (US$ Million) Market Share by Region (2016-2021))
    Table 7. Global Disease-Modifying Antirheumatic Drug Revenue Share by Region (2016-2021)
    Table 8. Global Disease-Modifying Antirheumatic Drug Sales (MT) Forecast by Region (2022-2027)
    Table 9. Global Disease-Modifying Antirheumatic Drug Sales Market Share Forecast by Region (2022-2027)
    Table 10. Global Disease-Modifying Antirheumatic Drug Revenue (US$ Million) Forecast by Region (2022-2027)
    Table 11. Global Disease-Modifying Antirheumatic Drug Revenue Share Forecast by Region (2022-2027)
    Table 12. Global Disease-Modifying Antirheumatic Drug Sales (MT) of Key Companies (2016-2021)
    Table 13. Global Disease-Modifying Antirheumatic Drug Sales Share by Company (2016-2021)
    Table 14. Global Disease-Modifying Antirheumatic Drug Revenue (US$ Million) by Company (2016-2021)
    Table 15. Global Disease-Modifying Antirheumatic Drug Revenue Share by Company (2016-2021)
    Table 16. Global Disease-Modifying Antirheumatic Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Disease-Modifying Antirheumatic Drug as of 2020)
    Table 17. Global Disease-Modifying Antirheumatic Drug Average Price (USD/MT) of Key Company (2016-2021)
    Table 18. Manufacturers Disease-Modifying Antirheumatic Drug Manufacturing Sites and Area Served
    Table 19. Manufacturers Disease-Modifying Antirheumatic Drug Product Type
    Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 21. Global Disease-Modifying Antirheumatic Drug Sales (MT) by Type (2016-2021)
    Table 22. Global Disease-Modifying Antirheumatic Drug Sales Share by Type (2016-2021)
    Table 23. Global Disease-Modifying Antirheumatic Drug Revenue (US$ Million) Market Share by Type (2016-2021)
    Table 24. Global Disease-Modifying Antirheumatic Drug Price (USD/MT) by Type (2016-2021)
    Table 25. Global Disease-Modifying Antirheumatic Drug Sales Share by Type (2022-2027)
    Table 26. Global Disease-Modifying Antirheumatic Drug Revenue (US$ Million) Market Share by Type (2022-2027) 
    Table 27. Global Disease-Modifying Antirheumatic Drug Revenue Share by Type (2022-2027)
    Table 28. Global Disease-Modifying Antirheumatic Drug Price (USD/MT) by Type (2022-2027)
    Table 29. Global Disease-Modifying Antirheumatic Drug Sales (MT) by Application (2016-2021) 
    Table 30. Global Disease-Modifying Antirheumatic Drug Sales Share by Application (2016-2021)
    Table 31. Global Disease-Modifying Antirheumatic Drug Revenue (US$ Million) Market Share by Application (2016-2021)
    Table 32. Global Disease-Modifying Antirheumatic Drug Price (USD/MT) by Application (2016-2021)
    Table 33. Global Disease-Modifying Antirheumatic Drug Sales (MT) by Application (2022-2027)
    Table 34. Global Disease-Modifying Antirheumatic Drug Sales Share by Application (2022-2027)
    Table 35. Global Disease-Modifying Antirheumatic Drug Revenue (US$ Million) Market Share by Application (2022-2027)
    Table 36. Global Disease-Modifying Antirheumatic Drug Revenue Share by Application (2022-2027)
    Table 37. Global Disease-Modifying Antirheumatic Drug Price (USD/MT) by Application (2022-2027)
    Table 38. North America Disease-Modifying Antirheumatic Drug Sales (MT) by Company (2016-2021)
    Table 39. North America Disease-Modifying Antirheumatic Drug Sales Market Share by Company (2016-2021)
    Table 40. North America Disease-Modifying Antirheumatic Drug Revenue by Company (2016-2021) & (US$ Million)
    Table 41. North America Disease-Modifying Antirheumatic Drug Revenue Market Share by Company (2016-2021)
    Table 42. North America Disease-Modifying Antirheumatic Drug Sales by Type (2016-2021) & (MT)
    Table 43. North America Disease-Modifying Antirheumatic Drug Sales Market Share by Type (2016-2021)
    Table 44. North America Disease-Modifying Antirheumatic Drug Sales by Type (2022-2027) & (MT)
    Table 45. North America Disease-Modifying Antirheumatic Drug Sales Market Share by Type (2022-2027)
    Table 46. North America Disease-Modifying Antirheumatic Drug Sales by Application (2016-2021) & (MT)
    Table 47. North America Disease-Modifying Antirheumatic Drug Sales Market Share by Application (2016-2021)
    Table 48. North America Disease-Modifying Antirheumatic Drug Sales by Application (2022-2027) & (MT)
    Table 49. North America Disease-Modifying Antirheumatic Drug Sales Market Share by Application (2022-2027)
    Table 50. Europe Disease-Modifying Antirheumatic Drug Sales (MT) by Company (2016-2021)
    Table 51. Europe Disease-Modifying Antirheumatic Drug Sales Market Share by Company (2016-2021)
    Table 52. Europe Disease-Modifying Antirheumatic Drug Revenue by Company (2016-2021) & (US$ Million)
    Table 53. Europe Disease-Modifying Antirheumatic Drug Revenue Market Share by Company (2016-2021)
    Table 54. Europe Disease-Modifying Antirheumatic Drug Sales by Type (2016-2021) & (MT)
    Table 55. Europe Disease-Modifying Antirheumatic Drug Sales Market Share by Type (2016-2021)
    Table 56. Europe Disease-Modifying Antirheumatic Drug Sales by Type (2022-2027) & (MT)
    Table 57. Europe Disease-Modifying Antirheumatic Drug Sales Market Share by Type (2022-2027)
    Table 58. Europe Disease-Modifying Antirheumatic Drug Sales by Application (2016-2021) & (MT)
    Table 59. Europe Disease-Modifying Antirheumatic Drug Sales Market Share by Application (2016-2021)
    Table 60. Europe Disease-Modifying Antirheumatic Drug Sales by Application (2022-2027) & (MT)
    Table 61. Europe Disease-Modifying Antirheumatic Drug Sales Market Share by Application (2022-2027)
    Table 62. China Disease-Modifying Antirheumatic Drug Sales (MT) by Company (2016-2021)
    Table 63. China Disease-Modifying Antirheumatic Drug Sales Market Share by Company (2016-2021)
    Table 64. China Disease-Modifying Antirheumatic Drug Revenue by Company (2016-2021) & (US$ Million)
    Table 65. China Disease-Modifying Antirheumatic Drug Revenue Market Share by Company (2016-2021)
    Table 66. China Disease-Modifying Antirheumatic Drug Sales by Type (2016-2021) & (MT)
    Table 67. China Disease-Modifying Antirheumatic Drug Sales Market Share by Type (2016-2021)
    Table 68. China Disease-Modifying Antirheumatic Drug Sales by Type (2022-2027) & (MT)
    Table 69. China Disease-Modifying Antirheumatic Drug Sales Market Share by Type (2022-2027)
    Table 70. China Disease-Modifying Antirheumatic Drug Sales by Application (2016-2021) & (MT)
    Table 71. China Disease-Modifying Antirheumatic Drug Sales Market Share by Application (2016-2021)
    Table 72. China Disease-Modifying Antirheumatic Drug Sales by Application (2022-2027) & (MT)
    Table 73. China Disease-Modifying Antirheumatic Drug Sales Market Share by Application (2022-2027)
    Table 74. Japan Disease-Modifying Antirheumatic Drug Sales (MT) by Company (2016-2021)
    Table 75. Japan Disease-Modifying Antirheumatic Drug Sales Market Share by Company (2016-2021)
    Table 76. Japan Disease-Modifying Antirheumatic Drug Revenue by Company (2016-2021) & (US$ Million)
    Table 77. Japan Disease-Modifying Antirheumatic Drug Revenue Market Share by Company (2016-2021)
    Table 78. Japan Disease-Modifying Antirheumatic Drug Sales by Type (2016-2021) & (MT)
    Table 79. Japan Disease-Modifying Antirheumatic Drug Sales Market Share by Type (2016-2021)
    Table 80. Japan Disease-Modifying Antirheumatic Drug Sales by Type (2022-2027) & (MT)
    Table 81. Japan Disease-Modifying Antirheumatic Drug Sales Market Share by Type (2022-2027)
    Table 82. Japan Disease-Modifying Antirheumatic Drug Sales by Application (2016-2021) & (MT)
    Table 83. Japan Disease-Modifying Antirheumatic Drug Sales Market Share by Application (2016-2021)
    Table 84. Japan Disease-Modifying Antirheumatic Drug Sales by Application (2022-2027) & (MT)
    Table 85. Japan Disease-Modifying Antirheumatic Drug Sales Market Share by Application (2022-2027)
    Table 86. Southeast Asia Disease-Modifying Antirheumatic Drug Sales (MT) by Company (2016-2021)
    Table 87. Southeast Asia Disease-Modifying Antirheumatic Drug Sales Market Share by Company (2016-2021)
    Table 88. Southeast Asia Disease-Modifying Antirheumatic Drug Revenue by Company (2016-2021) & (US$ Million)
    Table 89. Southeast Asia Disease-Modifying Antirheumatic Drug Revenue Market Share by Company (2016-2021)
    Table 90. Southeast Asia Disease-Modifying Antirheumatic Drug Sales by Type (2016-2021) & (MT)
    Table 91. Southeast Asia Disease-Modifying Antirheumatic Drug Sales Market Share by Type (2016-2021)
    Table 92. Southeast Asia Disease-Modifying Antirheumatic Drug Sales by Type (2022-2027) & (MT)
    Table 93. Southeast Asia Disease-Modifying Antirheumatic Drug Sales Market Share by Type (2022-2027)
    Table 94. Southeast Asia Disease-Modifying Antirheumatic Drug Sales by Application (2016-2021) & (MT)
    Table 95. Southeast Asia Disease-Modifying Antirheumatic Drug Sales Market Share by Application (2016-2021)
    Table 96. Southeast Asia Disease-Modifying Antirheumatic Drug Sales by Application (2022-2027) & (MT)
    Table 97. Southeast Asia Disease-Modifying Antirheumatic Drug Sales Market Share by Application (2022-2027)
    Table 98. India Disease-Modifying Antirheumatic Drug Sales (MT) by Company (2016-2021)
    Table 99. India Disease-Modifying Antirheumatic Drug Sales Market Share by Company (2016-2021)
    Table 100. India Disease-Modifying Antirheumatic Drug Revenue by Company (2016-2021) & (US$ Million)
    Table 101. India Disease-Modifying Antirheumatic Drug Revenue Market Share by Company (2016-2021)
    Table 102. India Disease-Modifying Antirheumatic Drug Sales by Type (2016-2021) & (MT)
    Table 103. India Disease-Modifying Antirheumatic Drug Sales Market Share by Type (2016-2021)
    Table 104. India Disease-Modifying Antirheumatic Drug Sales by Type (2022-2027) & (MT)
    Table 105. India Disease-Modifying Antirheumatic Drug Sales Market Share by Type (2022-2027)
    Table 106. India Disease-Modifying Antirheumatic Drug Sales by Application (2016-2021) & (MT)
    Table 107. India Disease-Modifying Antirheumatic Drug Sales Market Share by Application (2016-2021)
    Table 108. India Disease-Modifying Antirheumatic Drug Sales by Application (2022-2027) & (MT)
    Table 109. India Disease-Modifying Antirheumatic Drug Sales Market Share by Application (2022-2027)
    Table 110. AbbVie Corporation Information
    Table 111. AbbVie Description and Business Overview
    Table 112. AbbVie Disease-Modifying Antirheumatic Drug Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
    Table 113. AbbVie Disease-Modifying Antirheumatic Drug Product
    Table 114. AbbVie Recent Development
    Table 115. Amgen Corporation Information
    Table 116. Amgen Description and Business Overview
    Table 117. Amgen Disease-Modifying Antirheumatic Drug Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
    Table 118. Amgen Disease-Modifying Antirheumatic Drug Product
    Table 119. Amgen Recent Development
    Table 120. Pfizer Corporation Information
    Table 121. Pfizer Description and Business Overview
    Table 122. Pfizer Disease-Modifying Antirheumatic Drug Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
    Table 123. Pfizer Disease-Modifying Antirheumatic Drug Product
    Table 124. Pfizer Recent Development
    Table 125. Roche Holding AG Corporation Information
    Table 126. Roche Holding AG Description and Business Overview
    Table 127. Roche Holding AG Disease-Modifying Antirheumatic Drug Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
    Table 128. Roche Holding AG Disease-Modifying Antirheumatic Drug Product
    Table 129. Roche Holding AG Recent Development
    Table 130. Novartis International AG Corporation Information
    Table 131. Novartis International AG Description and Business Overview
    Table 132. Novartis International AG Disease-Modifying Antirheumatic Drug Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
    Table 133. Novartis International AG Disease-Modifying Antirheumatic Drug Product
    Table 134. Novartis International AG Recent Development
    Table 135. Johnson & Johnson Corporation Information
    Table 136. Johnson & Johnson Description and Business Overview
    Table 137. Johnson & Johnson Disease-Modifying Antirheumatic Drug Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
    Table 138. Johnson & Johnson Disease-Modifying Antirheumatic Drug Product
    Table 139. Johnson & Johnson Recent Development
    Table 140. Bristol-Myers Squibb Corporation Information
    Table 141. Bristol-Myers Squibb Description and Business Overview
    Table 142. Bristol-Myers Squibb Disease-Modifying Antirheumatic Drug Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
    Table 143. Bristol-Myers Squibb Disease-Modifying Antirheumatic Drug Product
    Table 144. Bristol-Myers Squibb Recent Development
    Table 145. Merck Corporation Information
    Table 146. Merck Disease-Modifying Antirheumatic Drug Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
    Table 147. Merck Description and Business Overview
    Table 148. Merck Disease-Modifying Antirheumatic Drug Product
    Table 149. Merck Recent Development
    Table 150. UCB S.A. Corporation Information
    Table 151. UCB S.A. Disease-Modifying Antirheumatic Drug Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
    Table 152. UCB S.A. Description and Business Overview
    Table 153. UCB S.A. Disease-Modifying Antirheumatic Drug Product
    Table 154. UCB S.A. Recent Development
    Table 155. Eli Lilly and Company Corporation Information
    Table 156. Eli Lilly and Company Description and Business Overview
    Table 157. Eli Lilly and Company Disease-Modifying Antirheumatic Drug Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
    Table 158. Eli Lilly and Company Disease-Modifying Antirheumatic Drug Product
    Table 159. Eli Lilly and Company Recent Development
    Table 160. Production Base and Market Concentration Rate of Raw Material
    Table 161. Key Suppliers of Raw Materials
    Table 162. Disease-Modifying Antirheumatic Drug Distributors List
    Table 163. Disease-Modifying Antirheumatic Drug Customers List
    Table 164. Disease-Modifying Antirheumatic Drug Market Trends
    Table 165. Disease-Modifying Antirheumatic Drug Market Drivers
    Table 166. Disease-Modifying Antirheumatic Drug Market Challenges
    Table 167. Disease-Modifying Antirheumatic Drug Market Restraints
    Table 168. Research Programs/Design for This Report
    Table 169. Key Data Information from Secondary Sources
    Table 170. Key Data Information from Primary Sources
List of Figures
    Figure 1. Disease-Modifying Antirheumatic Drug Product Picture
    Figure 2. Global Disease-Modifying Antirheumatic Drug Sales Market Share by Type in 2021 & 2027
    Figure 3. Type I Product Picture
    Figure 4. Type II Product Picture
    Figure 5. Global Disease-Modifying Antirheumatic Drug Sales Market Share by Application in 2021 & 2027
    Figure 6. Pharmaceutical Industry Examples
    Figure 7. Hospital and Clinic Examples
    Figure 8. Other Examples
    Figure 9. Global Disease-Modifying Antirheumatic Drug Sales, (US$ Million), 2016 VS 2021 VS 2027
    Figure 10. Global Disease-Modifying Antirheumatic Drug Sales Growth Rate (2016-2027) & (US$ Million)
    Figure 11. Global Disease-Modifying Antirheumatic Drug Sales (MT) Growth Rate (2016-2027)
    Figure 12. Global Disease-Modifying Antirheumatic Drug Price Trends Growth Rate (2016-2027) (USD/MT)
    Figure 13. Global Disease-Modifying Antirheumatic Drug Revenue Market Share by Region: 2016 VS 2021
    Figure 14. Global Disease-Modifying Antirheumatic Drug Revenue Market Share by Region: 2021 VS 2027
    Figure 15. North America Disease-Modifying Antirheumatic Drug Revenue (Million USD) Growth Rate (2016-2027)
    Figure 16. North America Disease-Modifying Antirheumatic Drug Sales (MT) Growth Rate (2016-2027)
    Figure 17. Europe Disease-Modifying Antirheumatic Drug Revenue (Million USD) Growth Rate (2016-2027)
    Figure 18. Europe Disease-Modifying Antirheumatic Drug Sales (Million USD) Growth Rate (2016-2027)
    Figure 19. China Disease-Modifying Antirheumatic Drug Revenue (Million USD) Growth Rate (2016-2027)
    Figure 20. China Disease-Modifying Antirheumatic Drug Sales (Million USD) and Growth Rate (2016-2027)
    Figure 21. Japan Disease-Modifying Antirheumatic Drug Revenue (Million USD) Growth Rate (2016-2027)
    Figure 22. Japan Disease-Modifying Antirheumatic Drug Sales (Million USD) Growth Rate (2016-2027)
    Figure 23. Southeast Asia Disease-Modifying Antirheumatic Drug Revenue (Million USD) Growth Rate (2016-2027)
    Figure 24. Southeast Asia Disease-Modifying Antirheumatic Drug Sales (Million USD) Growth Rate (2016-2027)
    Figure 25. India Disease-Modifying Antirheumatic Drug Revenue (Million USD) Growth Rate (2016-2027)
    Figure 26. India Disease-Modifying Antirheumatic Drug Sales (Million USD) Growth Rate (2016-2027)
    Figure 27. Global 5 Largest Disease-Modifying Antirheumatic Drug Players Market Share by Revenue in Disease-Modifying Antirheumatic Drug: 2016 & 2020
    Figure 28. Disease-Modifying Antirheumatic Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
    Figure 29. Global Disease-Modifying Antirheumatic Drug Revenue Share by Type (2016-2021)
    Figure 30. Global Disease-Modifying Antirheumatic Drug Revenue Growth Rate by Type in 2016 & 2020
    Figure 31. Global Disease-Modifying Antirheumatic Drug Revenue Share by Application (2016-2021)
    Figure 32. Global Disease-Modifying Antirheumatic Drug Revenue Growth Rate by Application in 2016 & 2020
    Figure 33. North America Disease-Modifying Antirheumatic Drug Sales Market Share by Type in 2020
    Figure 34. North America Disease-Modifying Antirheumatic Drug Sales Market Share by Application in 2020
    Figure 35. Europe Disease-Modifying Antirheumatic Drug Sales Market Share by Type in 2020
    Figure 36. Europe Disease-Modifying Antirheumatic Drug Sales Market Share by Application in 2020
    Figure 37. China Disease-Modifying Antirheumatic Drug Sales Market Share by Type in 2020
    Figure 38. China Disease-Modifying Antirheumatic Drug Sales Market Share by Application in 2020
    Figure 39. Japan Disease-Modifying Antirheumatic Drug Sales Market Share by Type in 2020
    Figure 40. Japan Disease-Modifying Antirheumatic Drug Sales Market Share by Application in 2020
    Figure 41. Southeast Asia Disease-Modifying Antirheumatic Drug Sales Market Share by Type in 2020
    Figure 42. Southeast Asia Disease-Modifying Antirheumatic Drug Sales Market Share by Application in 2020
    Figure 43. India Disease-Modifying Antirheumatic Drug Sales Market Share by Type in 2020
    Figure 44. India Disease-Modifying Antirheumatic Drug Sales Market Share by Application in 2020
    Figure 45. Key Raw Materials Price Trend
    Figure 46. Manufacturing Cost Structure of Disease-Modifying Antirheumatic Drug 
    Figure 47. Manufacturing Process Analysis of Disease-Modifying Antirheumatic Drug
    Figure 48. Disease-Modifying Antirheumatic Drug Industrial Chain Analysis
    Figure 49. Channels of Distribution
    Figure 50. Distributors Profiles
    Figure 51. Bottom-up and Top-down Approaches for This Report
    Figure 52. Data Triangulation 
    Figure 53. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
AbbVie
Amgen
Pfizer
Roche Holding AG
Novartis International AG
Johnson & Johnson
Bristol-Myers Squibb
Merck
UCB S.A.
Eli Lilly and Company
Frequently Asked Questions
Disease-Modifying Antirheumatic Drug report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Disease-Modifying Antirheumatic Drug report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Disease-Modifying Antirheumatic Drug report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Wood Processor

The global Wood Processor market is segmented by company, region (country), by Type, and by Appli ... Read More